Information
Overview
- Summary
- Plasmapp, a plasma-based medical solution company, founded in 2015 as a KAIST physics lab startup. A recognized entity as a preliminary unicorn, one of the top 100 material, parts, and equipment startups, and an innovative medical device company, based on its outstanding plasma technology. Over 187 patent applications and the Korea Technology Grand Prize, a testament to its technological prowess. A provider of reliable plasma technologies across the prevention, rehabilitation, and treatment medical industries. A leader in the global market with innovative solutions for medical device sterilization and implant surface treatment. Contributions to the secondary battery manufacturing sector through industrial plasma equipment development. A mission to safeguard medical devices worldwide, ensuring a healthier life for humankind.Plasmapp, a plasma-based medical solution company, founded in 2015 as a KAIST physics lab startup. A recognized entity as a preliminary unicorn, one of the top 100 material, parts, and equipment startups, and an innovative medical device company, based on its outstanding plasma technology. Over 187 patent applications and the Korea Technology Grand Prize, a testament to its technological prowess. A provider of reliable plasma technologies across the prevention, rehabilitation, and treatment medical industries. A leader in the global market with innovative solutions for medical device sterilization and implant surface treatment. Contributions to the secondary battery manufacturing sector through industrial plasma equipment development. A mission to safeguard medical devices worldwide, ensuring a healthier life for humankind.
- Key Products/Technologies
- The STERLINK™ series, a world-leading low-temperature plasma sterilization solution. Maximized sterilization efficiency through sterilant direct injection technology and impermeable sterile packaging. Prevention of thermal damage to delicate medical devices and assurance of user safety during sterilization. The STERLINK™ MINI model, a compact device with a 7-liter chamber (206mm x 346mm x 113mm), completing sterilization within 7 minutes in STERPACK® mode and 18 minutes in STERLOAD mode. The STERLINK™ FPS-15s Plus, available in 7-liter and 14-liter chamber models. Provision of diverse models like STERLINK™ U-510 and STERLINK™ Plus, suitable for a wide range of medical environments.The STERLINK™ series, a world-leading low-temperature plasma sterilization solution. Maximized sterilization efficiency through sterilant direct injection technology and impermeable sterile packaging. Prevention of thermal damage to delicate medical devices and assurance of user safety during sterilization. The STERLINK™ MINI model, a compact device with a 7-liter chamber (206mm x 346mm x 113mm), completing sterilization within 7 minutes in STERPACK® mode and 18 minutes in STERLOAD mode. The STERLINK™ FPS-15s Plus, available in 7-liter and 14-liter chamber models. Provision of diverse models like STERLINK™ U-510 and STERLINK™ Plus, suitable for a wide range of medical environments.
- The ACTILINK™ series, a premier surface treatment solution for implant regenerative activation. Utilization of vacuum plasma technology for impurity removal and surface energy increase on medical implant surfaces. Enhanced biocompatibility, shortened surgical healing time, and increased success rates with the activated surface. The ACTILINK™ Reborn model, featuring rapid processing within 60 seconds and no requirement for cooling or drying time. A technology significantly improving implant osseointegration performance, differentiating itself from conventional UV and argon plasma methods.The ACTILINK™ series, a premier surface treatment solution for implant regenerative activation. Utilization of vacuum plasma technology for impurity removal and surface energy increase on medical implant surfaces. Enhanced biocompatibility, shortened surgical healing time, and increased success rates with the activated surface. The ACTILINK™ Reborn model, featuring rapid processing within 60 seconds and no requirement for cooling or drying time. A technology significantly improving implant osseointegration performance, differentiating itself from conventional UV and argon plasma methods.
- STIMLINK™, a low-temperature plasma stimulative therapy solution for maximizing treatment efficiency of biological tissues. An innovative treatment approach employing vacuum plasma sterilization and stimulative activation technology. Stable and effective skin treatment without thermal damage in dermatological applications. A plasma technology-based solution applicable across the prevention, rehabilitation, and treatment medical industries.STIMLINK™, a low-temperature plasma stimulative therapy solution for maximizing treatment efficiency of biological tissues. An innovative treatment approach employing vacuum plasma sterilization and stimulative activation technology. Stable and effective skin treatment without thermal damage in dermatological applications. A plasma technology-based solution applicable across the prevention, rehabilitation, and treatment medical industries.
- LJPS®, an industrial plasma device for secondary battery manufacturing. Recognized by major corporations like LG and Samsung as a top expert plasma treatment solution for separator film surface treatment in rechargeable batteries. A demonstration of plasma technology expertise and commercialization beyond the medical field into industrial sectors. Capability to provide smart plasma application solutions across various industries.LJPS®, an industrial plasma device for secondary battery manufacturing. Recognized by major corporations like LG and Samsung as a top expert plasma treatment solution for separator film surface treatment in rechargeable batteries. A demonstration of plasma technology expertise and commercialization beyond the medical field into industrial sectors. Capability to provide smart plasma application solutions across various industries.
- Core Advantages
- Proprietary bio-plasma deep tech originating from a KAIST physics lab. Possession of over 187 patent applications and 214 intellectual property rights, including designs and trademarks. Recipient of the Korea Technology Grand Prize and multiple invention awards. Securing exclusive rights to plasma technology and strengthening its global patent portfolio through continuous R&D efforts.Proprietary bio-plasma deep tech originating from a KAIST physics lab. Possession of over 187 patent applications and 214 intellectual property rights, including designs and trademarks. Recipient of the Korea Technology Grand Prize and multiple invention awards. Securing exclusive rights to plasma technology and strengthening its global patent portfolio through continuous R&D efforts.
- Provision of the world's fastest and most efficient low-temperature plasma sterilization solutions. The STERLINK™ MINI boasting ultra-fast sterilization cycles of around 7 minutes, optimized for small medical facilities. Significant economic and efficiency benefits, including a 3x increase in instrument lifespan and over 30x increase in surgical tool turnover compared to conventional large autoclaves. A pioneering role in opening up an untapped market, being the first non-US company to receive US FDA clearance for a mini plasma sterilizer.Provision of the world's fastest and most efficient low-temperature plasma sterilization solutions. The STERLINK™ MINI boasting ultra-fast sterilization cycles of around 7 minutes, optimized for small medical facilities. Significant economic and efficiency benefits, including a 3x increase in instrument lifespan and over 30x increase in surgical tool turnover compared to conventional large autoclaves. A pioneering role in opening up an untapped market, being the first non-US company to receive US FDA clearance for a mini plasma sterilizer.
- Implant surface activation technology dramatically enhancing implant biocompatibility and osseointegration success rates. ACTILINK™ as the world's first implant surface activator to receive European CE MDR certification for use immediately prior to surgery. Effective removal of hydrocarbon contaminants from implant surfaces and creation of a hydrophilic surface through vacuum plasma technology. A device offering rapid processing within 60 seconds and high reliability for over 3,000 cycles. Technological capability to expand applications across various implant fields, including dental, orthopedic, and plastic surgery.Implant surface activation technology dramatically enhancing implant biocompatibility and osseointegration success rates. ACTILINK™ as the world's first implant surface activator to receive European CE MDR certification for use immediately prior to surgery. Effective removal of hydrocarbon contaminants from implant surfaces and creation of a hydrophilic surface through vacuum plasma technology. A device offering rapid processing within 60 seconds and high reliability for over 3,000 cycles. Technological capability to expand applications across various implant fields, including dental, orthopedic, and plastic surgery.
- An extensive global network established through product exports to over 50 countries worldwide. Acquisition of stringent regulatory clearances from key countries and regions, including US FDA, European CE-MDD and CE MDR, Health Canada, Russian RZN, Colombian INVIMA, and Eurasian EAC. Completion of international quality management system certifications such as ISO 13485, GMP, and MDSAP. Enhanced local customer service and tailored solutions through the establishment of Plasmapp America (USA) and Plasmapp Europe (Germany) branches. Acceleration of overseas market expansion through ODM contract discussions and strategic alliances with global medical device manufacturers.An extensive global network established through product exports to over 50 countries worldwide. Acquisition of stringent regulatory clearances from key countries and regions, including US FDA, European CE-MDD and CE MDR, Health Canada, Russian RZN, Colombian INVIMA, and Eurasian EAC. Completion of international quality management system certifications such as ISO 13485, GMP, and MDSAP. Enhanced local customer service and tailored solutions through the establishment of Plasmapp America (USA) and Plasmapp Europe (Germany) branches. Acceleration of overseas market expansion through ODM contract discussions and strategic alliances with global medical device manufacturers.
- A diversified business portfolio extending beyond medical device sterilization and implant surface treatment to include plasma stimulative therapy and industrial plasma devices for secondary battery manufacturing. Demonstration of plasma technology's applicability across both medical and industrial sectors. Continuous efforts in developing innovative new products and expanding application areas based on bio-plasma technology. A strategy for securing stable growth drivers through diversified business segments.A diversified business portfolio extending beyond medical device sterilization and implant surface treatment to include plasma stimulative therapy and industrial plasma devices for secondary battery manufacturing. Demonstration of plasma technology's applicability across both medical and industrial sectors. Continuous efforts in developing innovative new products and expanding application areas based on bio-plasma technology. A strategy for securing stable growth drivers through diversified business segments.
- Target Industries
- Medical Industry (across prevention, rehabilitation, and treatment medical sectors)Medical Industry (across prevention, rehabilitation, and treatment medical sectors)
- Dentistry (implant sterilization and surface activation)Dentistry (implant sterilization and surface activation)
- Orthopedics (implant surface activation)Orthopedics (implant surface activation)
- Plastic Surgery (implant surface activation)Plastic Surgery (implant surface activation)
- Dermatology (plasma stimulative therapy)Dermatology (plasma stimulative therapy)
- Veterinary Medicine (medical device sterilization)Veterinary Medicine (medical device sterilization)
- Secondary Battery Manufacturing Industry (separator film surface treatment)Secondary Battery Manufacturing Industry (separator film surface treatment)
- Major Markets
- United Arab EmiratesUnited Arab Emirates
- South Korea, Japan, Malaysia, Saudi ArabiaSouth Korea, Japan, Malaysia, Saudi Arabia
- Germany, European Union countries, RussiaGermany, European Union countries, Russia
- United States, CanadaUnited States, Canada
- AustraliaAustralia
- Brazil, ColombiaBrazil, Colombia
- Certifications/Patents
- Over 187 patent applications and 214 intellectual property rights, including designs and trademarks. 22% of 59 registered patents are international patents.Over 187 patent applications and 214 intellectual property rights, including designs and trademarks. 22% of 59 registered patents are international patents.
- US Food and Drug Administration (FDA) Class II Medical Device clearance (STERLINK mini).US Food and Drug Administration (FDA) Class II Medical Device clearance (STERLINK mini).
- European CE-MDD certification (STERLINK 15sp, STERLINK mini, STERPACK).European CE-MDD certification (STERLINK 15sp, STERLINK mini, STERPACK).
- European CE MDR certification (ACTILINK).European CE MDR certification (ACTILINK).
- Health Canada certification.Health Canada certification.
- Russian Federal Service for Surveillance in Healthcare (RZN) certification.Russian Federal Service for Surveillance in Healthcare (RZN) certification.
- Colombian INVIMA certification (STERLINK FPS-15s Plus).Colombian INVIMA certification (STERLINK FPS-15s Plus).
- Eurasian Conformity (EAC) certification.Eurasian Conformity (EAC) certification.
- Good Manufacturing Practice (GMP) certification.Good Manufacturing Practice (GMP) certification.
- ISO 13485 (Medical Devices Quality Management System) certification.ISO 13485 (Medical Devices Quality Management System) certification.
- Medical Device Single Audit Program (MDSAP) certification.Medical Device Single Audit Program (MDSAP) certification.
- ISO 9001, ISO 14001 certifications.ISO 9001, ISO 14001 certifications.
- Korea Technology Grand Prize award.Korea Technology Grand Prize award.
- Minister of Health and Welfare Commendation (New Technology Medical Device).Minister of Health and Welfare Commendation (New Technology Medical Device).
- Selected as a Preliminary Unicorn by the Ministry of SMEs and Startups.Selected as a Preliminary Unicorn by the Ministry of SMEs and Startups.
- New Excellent Technology (NET) certification from the Ministry of Trade, Industry and Energy.New Excellent Technology (NET) certification from the Ministry of Trade, Industry and Energy.
- Designated as an Innovative Medical Device Company.Designated as an Innovative Medical Device Company.
Introduction
Location
476 Gangnam-daero, Gangnam District, Seoul, South Korea
클릭하여 위치 살펴보기
